MedPath

Quality of Life and Liver Metastases

Completed
Conditions
Colorectal Liver Metastases
Quality of Life
Registration Number
NCT00184834
Lead Sponsor
Radboud University Medical Center
Brief Summary

An increasing aggressiveness in the surgical approach of colorectal liver metastases is observed. This seems only justified when, besides prolongation of survival, also the health status of patients is considered. The aim of this prospective study is to investigate the impact of surgery on health-related quality of life in this specific patient population operated for colorectal liver metastases.Furthermore, as the indications for hepatic resection are broadened and patients with more extensive liver disease are operated on, the chance of non operable disease at laparotomy will increase. The effects of such an event on HRQol are also studied.

Detailed Description

In a prospective study several patients groups were identified. Patients undergoing liver resection and/or local ablative therapy. Patients with non operable disease at (explorative) laparotomy and outpatients with non operable disease as shown during work up for liver resection. Several validated instruments on HRQoL were ompleted preoperatively (baseline), a half month after operation and then every three months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria

colorectal liver metastases (operable and non operable disease) and participation by means of filling in quality of life instruments

Read More
Exclusion Criteria

drop out and therefore loss of quality of life instruments

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Radboud University Nijmegen Medical Centre

🇳🇱

Nijmegen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath